Fujitsu, a leading provider of business, information technology, and communications solutions, has announced that it was chosen by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to implement a multi-node regional fibre optic network allowing researchers to access and share critical data residing in remote data centres. NIAID's selection of the Fujitsu FLASHWAVE 7420 Metro/Enterprise WDM Platform, NETSMART 1500 Management System and professional services, will ensure the agency benefits from tunable bandwidths reaching 40Gb per second performance; sub-microsecond latency; multi-protocol, multi-application support; remote monitoring and management; and valuable training. 

NIAID conducts and supports research to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses.

Source: 4 Traders